Preclinical Activity of the Vascular Disrupting Agent OXi4503 against Head and Neck Cancer

Preclinical Activity of the Vascular Disrupting Agent OXi4503 against Head and Neck Cancer

Vascular disrupting agents (VDAs) represent a relatively distinct class of agents that target established blood vessels in tumors. In this study, we examined the preclinical activity of the second-generation VDA OXi4503 against human head and neck squamous cell carcinoma (HNSCC). Studies were perfor...

Full description

Bibliographic Details
Main Authors: Katelyn D. Bothwell, Margaret Folaron, Mukund Seshadri
Format: Article
Language:English
Published: MDPI AG 2016-01-01
Series:Cancers
Subjects:
head and neck squamous cell carcinomas
angiogenesis
vascular disrupting agents
bioluminescence imaging
magnetic resonance imaging
Online Access:http://www.mdpi.com/2072-6694/8/1/11

Internet

http://www.mdpi.com/2072-6694/8/1/11

Similar Items